ACR | LAB Urine Analysis Test System Evaluation of Performance
Completed · Not applicable
Conditions studied: Diabetes, Hypertension
In brief
The ACR LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The test is for the qualitative and semi- quantitative detection of Albumin, Creatinine, and the Albumin-to- Creatinine Ratio. The device is composed of a kit and a smartphone application using an image recognition algorithm. The degree of agreement of the ACR \| LAB as compared to the comparator device will be tested. Urine samples will be tested by a separate professional user on each device.
Key facts
- Study ID
- NCT04466501
- Run by
- Healthy.io Ltd.
- People needed
- 375
- Starts
- 2019-06-30
- Expected to finish
- 2019-09-30
- Last updated by the study team
- 2020-07-10
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Men and women 18-80 years of age;
- Subjects who are healthy or pregnant; or
- Subjects diagnosed with a disease that normally represents itself with an abnormal concentration of albumin:
- Diabetes Type I/Type II,
- Hypertension,
- Any kidney disease,
- Other relevant conditions.
- Subjects with any pathological findings which might be identified by the urine test (according to the physician discretion);
- Subject is capable and willing to provide informed consent;
- Subject has facility with both hands
- Subject is capable and willing to adhere to the study procedures.
Where it is running
- Atlanta Center for Medical Research — Atlanta, Georgia, United States
- Central Kentucky Research Associates — Lexington, Kentucky, United States
- AccuMed research associates — Garden City, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.